Bandingkan Harga & Kinerja Indo Straits Tbk. (PTIS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo Straits Tbk. dan Organon Pharma Indonesia Tbk.: Indo Straits Tbk. diperdagangkan di Rp260 (kapitalisasi pasar 144,14 M, volume 24 jam 66,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indo Straits Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| PTIS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 144,14 M | 104,4 M |
Volume | 66,9 rb | — |
Lot | 669 | — |
Perputaran | 17,5 jt | — |
Harga Rata-rata | 261,64 | — |
Nilai Transaksi | 17,5 jt | — |
Harga Ekuilibrium Indikatif | 260 | — |
Volume Ekuilibrium Indikatif | 20 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo Straits Tbk.
PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Selengkapnya di halaman PTIS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
